SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-022311
Filing Date
2009-07-15
Accepted
2009-07-15 09:15:30
Documents
8
Period of Report
2009-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b76334oie8vk.htm 8-K 72981
2 EX-1.1 PLACEMENT AGENT AGREEMENT DATED AS OF JULY 15, 2009 b76334oiexv1w1.htm EX-1.1 164004
3 EX-4.1 FORM OF FIVE-YEAR WARRANT ISSUED TO INVESTORS b76334oiexv4w1.htm EX-4.1 64300
4 EX-4.2 FORM OF SHORT-TERM WARRANT ISSUED TO INVESTORS b76334oiexv4w2.htm EX-4.2 65788
5 EX-5.1 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. REGARDING b76334oiexv5w1.htm EX-5.1 8354
6 EX-10.1 FORM OF SUBSCRIPTION AGREEMENT b76334oiexv10w1.htm EX-10.1 57013
7 EX-99.1 PRESS RELEASE, DATED JULY 15, 2009 b76334oiexv99w1.htm EX-99.1 5825
8 GRAPHIC b76334oib7633401.gif GRAPHIC 4891
  Complete submission text file 0000950123-09-022311.txt   446714
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 09944950
SIC: 2836 Biological Products, (No Diagnostic Substances)